Aguilar-Salinas, Carlos Alberto

academic article in scopus

• Role of Presurgical Gut Microbial Diversity in Roux-en-Y Gastric Bypass Weight-Loss Response: A Cohort Study.  Lifestyle Genomics.  2024
• High levels of rheumatoid factor: association with thyroid antibodies and other analytical thyroid interferences in Sjögren's syndrome.  Clinical and Experimental Rheumatology.  2023
• Performance of the enhanced Sampson-NIH equation for VLDL-C and LDL-C in a population with familial combined hyperlipidemia.  Atherosclerosis.  2023
• The case for precision medicine in the prevention, diagnosis, and treatment of cardiometabolic diseases in low-income and middle-income countries.  Lancet Diabetes and Endocrinology,The.  2023
• A second update on mapping the human genetic architecture of COVID-19.  Nature.  2023
• Liraglutide in Prader Willi-Syndrome: The Importance of Placebo-Controlled Studies.  Journal of Clinical Endocrinology and Metabolism.  2023
• The Trend in the Prevalence of Diabetes Mellitus in the Mexican Indigenous Population From 2000 to 2018 2023
• HDL abnormalities in type 2 diabetes: Clinical implications.  Atherosclerosis.  2023
• Phase Angle as a Potential Screening Tool in Adults with Metabolic Diseases in Clinical Practice: A Systematic Review.  International Journal of Environmental Research and Public Health.  20. 2023
• Stratification in Heterozygous Familial Hypercholesterolemia: Imaging, Biomarkers, and Genetic Testing.  Current Atherosclerosis Reports.  2023
• Total body water and sicca symptoms in primary Sjögren¿s syndrome.  Clinical and Experimental Rheumatology.  40:2240-2244. 2022
• Arterial Stiffness and HbA1c: Association Mediated by Insulin Resistance in Hispanic Adults.  International Journal of Environmental Research and Public Health.  19. 2022
• Identification of glucose and insulin patterns during A 5-H glucose tolerance test and association with cardiometabolic risk factors.  Revista de Investigacion Clinica.  74:193-201. 2022
• New Therapies for Primary Hyperlipidemia.  Journal of Clinical Endocrinology and Metabolism.  107:1216-1224. 2022
• Serum Vitamin D Levels Are Associated With Increased COVID-19 Severity and Mortality Independent of Whole-Body and Visceral Adiposity.  Frontiers in Nutrition.  9. 2022
• Imputation Performance in Latin American Populations: Improving Rare Variants Representation With the Inclusion of Native American Genomes.  Frontiers in Genetics.  12. 2022
• A saturated map of common genetic variants associated with human height.  Nature.  610:704-712. 2022
• Autoimmune Thyroid Disease in Primary Sjögren¿s Syndrome: Real-life Screening Practice and Clinical Outcomes.  Current Rheumatology Reviews.  18:272-277. 2022
• Elevated serum uric acid is a facilitating mechanism for insulin resistance mediated accumulation of visceral adipose tissue.  Clinical Endocrinology.  96:707-718. 2022
• Epicardial adipose tissue thickness is associated with increased COVID-19 severity and mortality.  International Journal of Obesity.  46:866-873. 2022
• Triglyceride-rich lipoproteins and their remnants: Metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society.  European Heart Journal.  42:4791-4806. 2021
• A higher bacterial inward BCAA transport driven by Faecalibacterium prausnitzii is associated with lower serum levels of BCAA in early adolescents.  Molecular Medicine.  27. 2021
• Comparative assessment of LDL-C and VLDL-C estimation in familial combined hyperlipidemia using Sampson¿s, Martin¿s and Friedewald¿s equations.  Lipids in Health and Disease.  20. 2021
• Correction to: Identification of TBX15 as an adipose master trans regulator of abdominal obesity genes (Genome Medicine, (2021), 13, 1, (123), 10.1186/s13073-021-00939-2).  Genome Medicine.  13. 2021
• Familial hypertriglyceridemia: an entity with distinguishable features from other causes of hypertriglyceridemia.  Lipids in Health and Disease.  20. 2021
• Identification of TBX15 as an adipose master trans regulator of abdominal obesity genes.  Genome Medicine.  13. 2021
• LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred.  Lipids in Health and Disease.  20. 2021
• Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.  BMC Endocrine Disorders.  21. 2021
• Trends and age-period-cohort effects on hypertension mortality rates from 1998 to 2018 in Mexico.  Scientific Reports.  11. 2021
• Two novel variants in DYRK1B causative of AOMS3: expanding the clinical spectrum.  Orphanet Journal of Rare Diseases.  16. 2021
• Effect of gut microbial enterotypes on the association between habitual dietary fiber intake and insulin resistance markers in mexican children and adults.  Nutrients.  13. 2021
• Association between insulin resistance and arterial stiffness in mexican patients without type 2 diabetes La asociación entre la resistencia a la insulina y la rigidez arterial en pacientes mexicanos sin diabetes mellitus tipo 2.  Gaceta Medica de Mexico.  157:539-547. 2021
• Adaptive Metabolic and Inflammatory Responses Identified Using Accelerated Aging Metrics Are Linked to Adverse Outcomes in Severe SARS-CoV-2 Infection.  Journals of Gerontology - Series A Biological Sciences and Medical Sciences.  76:E117-E126. 2021
• Cost-effectiveness of a self-management and comprehensive training intervention in patients with type 2 diabetes up to 5 years of diagnosis in a specialized hospital in Mexico City.  BMJ Open Diabetes Research and Care.  9. 2021
• The trans-ancestral genomic architecture of glycemic traits.  Nature Genetics.  53:840-860. 2021
• Comparison of two electronic systems for obtaining diabetes care indicators in clinical practice.  Clinical Diabetes.  39:167-172. 2021
• Diabetes Awareness, Treatment, and Control among Mexico City Residents 2021
• Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes.  Diabetes and Metabolism.  47. 2021
• Unequal Impact of Structural Health Determinants and Comorbidity on COVID-19 Severity and Lethality in Older Mexican Adults: Considerations Beyond Chronological Aging.  Journals of Gerontology - Series A Biological Sciences and Medical Sciences.  76:e52-e59. 2021
• Clinician prescription of lipid-lowering drugs and achievement of treatment goals in patients with newly diagnosed type 2 diabetes mellitus.  BMJ Open Diabetes Research and Care.  9. 2021
• Increased visceral fat accumulation modifies the effect of insulin resistance on arterial stiffness and hypertension risk.  Nutrition Metabolism and Cardiovascular Diseases.  31:506-517. 2021
• Use of an electronic integral monitoring system for patients with diabetes to identify factors associated with an adequate glycemic goal and to measure quality of care.  Primary Care Diabetes.  15:162-168. 2021
• Physiological Network From Anthropometric and Blood Test Biomarkers.  Frontiers in Physiology.  11. 2021
• A high incidence of metabolic syndrome traits in mexicans points at obesity-related metabolic dysfunction.  Diabetes Metabolic Syndrome and Obesity: Targets and Therapy.  14:1073-1082. 2021
• Familial hypercholesterolemia in Mexico: Initial insights from the national registry.  Journal of Clinical Lipidology.  15:124-133. 2021
• Genome-Wide Association Study Identifies a Functional SIDT2 Variant Associated with HDL-C (High-Density Lipoprotein Cholesterol) Levels and Premature Coronary Artery Disease.  Arteriosclerosis Thrombosis and Vascular Biology.  41:2494-2508. 2021
• La asociación entre la resistencia a la insulina y la rigidez arterial en pacientes mexicanos sin diabetes mellitus tipo 2 Association between insulin resistance and arterial stiffness in Mexican patients without type 2 diabetes.  Gaceta Medica de Mexico.  157:522-530. 2021
• PRECISION MEDICINE FOR METABOLIC DISORDERS IN LOW- AND MIDDLE-INCOME COUNTRIES: AREAS OF OPPORTUNITY AND CHALLENGES FOR THE FUTURE.  Revista de Investigacion Clinica.  73:316-320. 2021
• Prevalence of diabetes and glycemic control in Mexico: national results from 2018 and 2020 Prevalencia de diabetes y control glucémico en México: resultados nacionales 2018 y 2020.  Salud Publica de Mexico.  63:725-733. 2021
• Reaching LDL-C Targets in Patients with Moderate, High, and Very High Risk for Cardiovascular Disease After Bariatric Surgery According to Different Guidelines.  Obesity Surgery.  31:2087-2096. 2021
• The influence of high-density lipoprotein (HDL) and HDL subfractions on insulin secretion and cholesterol efflux in pancreatic derived ß-cells.  Journal of Endocrinological Investigation.  44:1897-1904. 2021
• Validation and repurposing of the MSLCOVID- 19 score for prediction of severe COVID-19 using simple clinical predictors in a triage setting: The Nutri-CoV score.  PLoS ONE.  15. 2020
• Improvement of the 10-Year Atherosclerotic Cardiovascular Disease (ASCVD) Risk Following Bariatric Surgery.  Obesity Surgery.  30:3997-4003. 2020
• The type 2 diabetes-specific dementia risk score (DSDRS) is associated with frailty, cognitive and functional status amongst Mexican community-dwelling older adults.  BMC Geriatrics.  20. 2020
• Bloethics in the covid-19 pandemic research: Challenges and strategies.  Revista de Investigacion Clinica.  72:265-270. 2020
• The causal effect of obesity on prediabetes and insulin resistance reveals the important role of adipose tissue in insulin resistance.  PLoS Genetics.  16. 2020
• Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.  Journal of Clinical Endocrinology and Metabolism.  105. 2020
• Clinical characterization of data-driven diabetes subgroups in Mexicans using a reproducible machine learning approach.  BMJ Open Diabetes Research and Care.  8. 2020
• Environmental and intrinsic factors shaping gut microbiota composition and diversity and its relation to metabolic health in children and early adolescents: A population-based study.  Gut Microbes.  11:900-917. 2020
• The combination of insulin resistance and visceral adipose tissue estimation improves the performance of metabolic syndrome as a predictor of type 2 diabetes.  Diabetic Medicine.  37:1192-1201. 2020
• Remnant lipoproteins: Are they equal to or more atherogenic than LDL?.  Current Opinion in Lipidology.  31:132-139. 2020
• Bioethics in Medical Care Rationing During the Coronavirus Disease-19 Pandemic.  Revista de Investigacion Clinica.  73:1-5. 2020
• Metabolic Score for Visceral Fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health.  Clinical Nutrition.  39:1613-1621. 2020
• Intermittent Fasting as Part of the Management for T2DM: from Animal Models to Human Clinical Studies.  Current Diabetes Reports.  20. 2020
• Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action.  JAMA Cardiology.  5:217-229. 2020
• Development and Validation of a Software Linked to an Internet Portal That Facilitates the Medical Treatment and Empowerment of Patients with Type 2 Diabetes, Interaction with Medical Personnel, and the Generation of a Real-Time Registry.  Journal of diabetes science and technology.  15:525-527. 2020
• Implicaciones clínicas del retorno al trabajo durante la pandemia.  Salud Publica de Mexico.  63:147-147. 2020
• UNIVERSAL MASKING DURING COVID-19 PANDEMIC - CURRENT EVIDENCE AND CONTROVERSIES.  Revista de Investigacion Clinica.  72:144-150. 2020
• Associations of autozygosity with a broad range of human phenotypes.  Nature Communications.  10. 2019
• Attributable burden and expenditure of cardiovascular diseases and associated risk factors in mexico and other selected mega-countries.  International Journal of Environmental Research and Public Health.  16. 2019
• The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM¿) paradigm: Conceptual framework and therapeutic potential.  Cardiovascular Diabetology.  18. 2019
• Genetic contributors to serum uric acid levels in Mexicans and their effect on premature coronary artery disease.  International Journal of Cardiology.  279:168-173. 2019
• The SLC16A11 risk haplotype is associated with decreased insulin action, higher transaminases and large-size adipocytes.  European Journal of Endocrinology.  180:99-107. 2019
• Continuous glucose monitoring in the management of patients after gastric bypass.  Endocrinology Diabetes and Metabolism Case Reports.  2019. 2019
• Empowerment of patients with type 2 diabetes: Current perspectives.  Diabetes Metabolic Syndrome and Obesity: Targets and Therapy.  12:1311-1321. 2019
• FACTORS INFLUENCING ACHIEVEMENT OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL GOALS IN MEXICO: THE INTERNATIONAL CHOLESTEROL MANAGEMENT PRACTICE STUDY.  Revista de Investigacion Clinica.  71:408-416. 2019
• Fibroblast growth factor 21 and browning of white adipose tissue.  Frontiers in Physiology.  10. 2019
• Pathophysiological mechanisms linking type 2 diabetes and dementia: Review of evidence from clinical, translational and epidemiological research.  Current Diabetes Reviews.  15:456-470. 2019
• Prediction of incident hypertension and arterial stiffness using the non¿insulin-based metabolic score for insulin resistance (METS-IR) index.  Journal of Clinical Hypertension.  21:1063-1070. 2019
• Recent advances in managing/understanding the metabolic syndrome [version 1; peer review: 3 approved].  F1000Research.  8. 2019
• The Mexican consensus on nonalcoholic fatty liver disease Consenso mexicano de la enfermedad por hígado graso no alcohólico.  Revista de Gastroenterologia de Mexico.  84:69-99. 2019
• Low salivary amylase gene (AMY1) copy number is associated with obesity and gut prevotella abundance in mexican children and adults.  Nutrients.  10. 2018
• Optimization of kidney dysfunction prediction in diabetic kidney disease using targeted metabolomics.  Acta Diabetologica.  55:1151-1161. 2018
• Cholesterol efflux capacity of large, small and total HDL particles is unaltered by atorvastatin in patients with type 2 diabetes.  Atherosclerosis.  277:72-79. 2018
• The development of the Mexican Familial Hypercholesterolemia (FH) National Registry.  Atherosclerosis.  277:517-523. 2018
• Dyslipidemia in Mexico, a call for action.  Revista de Investigacion Clinica.  70:211-216. 2018
• Familial combined hyperlipidemia: Current knowledge, perspectives, and Controversies.  Revista de Investigacion Clinica.  70:224-236. 2018
• Lipid disorders: Advances in research and challenges in clinical practice.  Revista de Investigacion Clinica.  70:209-210. 2018
• Sucralose decreases insulin sensitivity in healthy subjects: A randomized controlled trial.  American Journal of Clinical Nutrition.  108:485-491. 2018
• Mexican carriers of the HNF1A p. E508K variant do not experiencean enhanced response to sulfonylureas.  Diabetes Care.  41:1726-1731. 2018
• Identification of a threshold to discriminate fasting hypertriglyceridemia with postprandial values.  Lipids in Health and Disease.  17. 2018
• Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS).  European Journal of Preventive Cardiology.  25:1087-1094. 2018
• METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes.  European Journal of Endocrinology.  178:533-544. 2018
• Searching for the Causal Variants of the Association between Hypertriglyceridemia and the Genome-Wide Association Studies-Derived Signals?: Take a Look in the Native American Populations.  Circulation. Cardiovascular genetics.  10. 2017
• Interaction Between Depression, Obesity, and Type 2 Diabetes: A Complex Picture.  Archives of Medical Research.  48:582-591. 2017
• Real time monitoring of children, and adults with mental disabilities using a low-cost non-invasive electronic device.  Micromachines.  8. 2017
• Prenatal docosahexaenoic acid supplementation does not affect nonfasting serum lipid and glucose concentrations of offspring at 4 years of age in a follow-up of a randomized controlled clinical trial in Mexico.  Journal of Nutrition.  147:242-247. 2017
• The panorama of familial hypercholesterolemia in Latin America: A systematic review.  Journal of Lipid Research.  57:2115-2129. 2016